Nikko Asset Management Americas, Inc. Bluebird Bio, Inc. Transaction History

Nikko Asset Management Americas, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $2.88 Million - $4.88 Million	-106,151 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$26.16 - $63.5 $3.73 Million - $9.05 Million	-142,568 Reduced 57.32%	106,151 $4.88 Million
Q4 2019 Feb 06, 2020	BUY	$46.96 - $61.67 $4.25 Million - $5.58 Million	90,546 Added 57.24%	248,719 $21.8 Million
Q3 2019 Oct 29, 2019	BUY	$59.47 - $93.1 $1.45 Million - $2.27 Million	24,387 Added 18.23%	158,173 $14.5 Million
Q2 2019 Jul 29, 2019	BUY	$75.84 - $105.21 $2.77 Million - $3.84 Million	36,485 Added 37.5%	133,786 $17 Million
Q1 2019 Apr 30, 2019	BUY	$64.44 - $104.11 $6.27 Million - $10.1 Million	97,301 New	97,301 $15.3 Million
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $17,966 - $28,351	-304 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$88.86 - $117.49 $27,013 - $35,716	304 New	304 $44,000

27M

191K

299K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $561M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.